-
11361por Simmons, Ruth, Sharp, Colin, Sims, Stuart, Kloverpris, Henrik, Goulder, Philip, Simmonds, Peter, Bowness, Paul, Klenerman, Paul“…Parvovirus 4 (PARV4) is a recently identified human virus that has been found in livers of patients infected with hepatitis C virus (HCV) and in bone marrow of individuals infected with human immunodeficiency virus (HIV). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11362por Ahmad, Waqar, Ijaz, Bushra, Javed, Fouzia T, Gull, Sana, Kausar, Humaira, Sarwar, Muhammad T, Asad, Sultan, Shahid, Imran, Sumrin, Aleena, Khaliq, Saba, Jahan, Shah, Pervaiz, Asim, Hassan, Sajida“…BACKGROUND: Hepatitis C can lead to liver fibrosis and cirrhosis. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
11363por Salvini, Filippo, Riva, Enrica, Salvatici, Elisabetta, Boehm, Günther, Jelinek, Jürgen, Banderali, Giuseppe, Giovannini, Marcello“…In this double-blind, randomized, placebo-controlled, explorative study, 20 newborns of hepatitis C virus-infected mothers who decided not to breast feed due to their concerns regarding their plasma viral load were randomly assigned to either a formula with 8 g/L of a specific prebiotic mixture (short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides, ratio 9:1) or a formula containing the same amount of maltodextrin (placebo). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11364por Chen, J-Y, Lin, C-Y, Wang, C-M, Lin, Y-T, Kuo, S-N, Shiu, C-F, Chang, S-W, Wu, J, Sheen, I-S“…Chronic hepatitis C virus (HCV) infection patients exhibit different sustained virological responses (SVRs) following the treatment with pegylated interferon-α (IFN-α) and ribavirin. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11365por Ali, Ijaz, Khan, Sanaullah, Attaullah, Sobia, Khan, Shahid Niaz, Khan, Jabbar, Siraj, Sami, Iqbal, Aqib, Swati, Zahoor A, Idrees, Muhammad“…BACKGROUND: Hepatitis C virus (HCV) genotype 3a is known to show comparatively better response to combination therapy than genotype 1 and 4. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11366por Shen, Tao, Zheng, Jiajia, Liang, Hua, Xu, Chunhui, Chen, Xiangmei, Zhang, Ting, Xu, Qiang, Lu, Fengmin“…RESULTS: In the present study, the majority of Tregs was identified as central memory phenotype in chronic hepatitis C patients compared with nearly equal contribution of naïve and central memory subsets in healthy individuals. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11367por Jahan, Shah, Khaliq, Saba, Samreen, Baila, Ijaz, Bushra, Khan, Mahwish, Ahmad, Waqar, Ashfaq, Usman Alli A, Hassan, Sajida“…BACKGROUND/AIM: Hepatitis C virus (HCV) is a major threat as almost 3% of the world's population (350 million individual) and 10% of the Pakistani population is chronically infected with this virus. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11368por Ranjith-Kumar, C. T., Wen, Yahong, Baxter, Nielson, Bhardwaj, Kanchan, Cheng Kao, C.“…RNA synthesis by the genotype 1b hepatitis C virus (HCV) polymerase (NS5B) transiently expressed in Human embryonic kidney 293T cells or liver hepatocytes was found to robustly stimulate RIG-I-dependent luciferase production from the interferon β promoter in the absence of exogenously provided ligand. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11369“…Compared to non-Asian-Americans, Asian-Americans had a significantly higher incidence of history of hepatitis B virus (HBV) infection (55.0% vs. 4.9%, P < 0.001), family history of HBV infection (12.5% vs. 0.0%, P < 0.001) and HCC (15.2% vs. 2.9%, P = 0.002), but lower incidence of history of hepatitis C virus (HCV) infection (37.5% vs. 61.6%, P < 0.001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11370por Anwar, Azlinda, Hosoya, Takamitsu, Leong, Kok Mun, Onogi, Hiroshi, Okuno, Yukiko, Hiramatsu, Toshiyuki, Koyama, Hiroko, Suzuki, Masaaki, Hagiwara, Masatoshi, Garcia-Blanco, Mariano A.“…As a remedy for this, we explored the use of compounds that interfere with the action of required host factors and describe here the characterization of a kinase inhibitor (SFV785), which has selective effects on NTRK1 and MAPKAPK5 kinase activity, and anti-viral activity on Hepatitis C, DENV and yellow fever viruses. SFV785 inhibited DENV propagation without inhibiting DENV RNA synthesis or translation. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11371por El-Maouche, Diala, Xu, Xiaoqiang, Cofrancesco, Joseph, Dobs, Adrian S, Brown, Todd T“…The cohort consisted of mostly African-American, middle-aged people with a high prevalence of illicit drug use, 50% HIV(+), and 39% hepatitis C(+). Osteoporosis was identified in 22% of subjects (24 men, 5 women), with the majority of cases (90%) attributable to osteoporosis at the lumbar spine. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11372por Jahan, Shah, Samreen, Baila, Khaliq, Saba, Ijaz, Bushra, Khan, Mahwish, Siddique, Muhammad Hassan, Ahmad, Waqar, Hassan, Sajida“…BACKGROUND: Hepatitis C virus (HCV) is a major health concern with almost 3% of the world's population (350 million individuals) and 10% of the Pakistani population chronically infected with this viral pathogen. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11373por Muazzam, Ambreen G, Qureshi, Saleem, Mansoor, Atika, Ali, Lubna, Iqbal, Musarrat, Siddiqi, Saima, Khan, Khalid M, Mazhar, Kehkashan“…CONCLUSION: True occult hepatitis C virus does not exist in our cohort. Residual viremia at the EOT stage merely reflects a difference in viral kinetics in various compartments that remains a target of immune response even after the end of antiviral therapy and is eventually cleared out at the sustained viral response (SVR).…”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11374“…Recombinant IFNs are used for the treatment of hepatitis C virus infection, multiple sclerosis, and certain malignancies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11375Viral Double-Strand RNA-Binding Proteins Can Enhance Innate Immune Signaling by Toll-Like Receptor 3por Lai, Yvonne, Yi, Guanghui, Chen, Alice, Bhardwaj, Kanchan, Tragesser, Brady J., Rodrigo A. Valverde, Zlotnick, Adam, Mukhopadhyay, Suchetana, Ranjith-Kumar, C. T., Kao, C. Cheng“…TLR3 signaling was examined in a lung epithelial cell line by quantifying cytokine production and in human embryonic kidney cells by quantifying luciferase reporter levels. Recombinant 1b hepatitis C virus polymerase was found to enhance TLR3 signaling in the lung epithelial BEAS-2B cells when added to the media along with either poly(I:C) or viral dsRNAs. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11376por Liu, Shu-Lin, Cheng, Chun-Chia, Chang, Chun-Chao, Mai, Fu-Der, Wang, Chia-Chi, Lee, Shui-Cheng, Ho, Ai-Sheng, Chen, Ling-Yun, Chang, Jungshan“…Moreover, we found that CRP and Hp were both lower in liver fibrosis of TAA-induced rats and clinical hepatitis C virus-infected patients. CONCLUSION: The results suggest that increased levels of CRP are an early sign of AFL in rats. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11377por MacPherson, Jamie I., Sidders, Ben, Wieland, Stefan, Zhong, Jin, Targett-Adams, Paul, Lohmann, Volker, Backes, Perdita, Delpuech-Adams, Oona, Chisari, Francis, Lewis, Marilyn, Parkinson, Tanya, Robertson, David L.“…Hepatitis C virus (HCV) is a global problem. To better understand HCV infection researchers employ in vitro HCV cell-culture (HCVcc) systems that use Huh-7 derived hepatoma cells that are particularly permissive to HCV infection. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11378por Yilmaz, Yusuf, Yonal, Oya, Kurt, Ramazan, Bayrak, Muharrem, Aktas, Bilge, Ozdogan, Osman“…OBJECTIVES: To assess the diagnostic ability of the APRI for prediction of fibrosis in patients with chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11379por Schiavini, Monica, Angeli, Elena, Mainini, Annalisa, Uberti-Foppa, Caterina, Zerbi, Pietro, Sagnelli, Caterina, Cargnel, Antonietta, Vago, Gianluca, Duca, Pier Giorgio, Giorgi, Riccardo, Rizzardini, Giuliano, Gubertini, Guido“…BACKGROUND: Chronic hepatitis C is more aggressive during HIV infection. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11380por Liu, Jiao, Ding, Xiong, Tang, Jia, Cao, Youde, Hu, Peng, Zhou, Fan, Shan, Xiaoliang, Cai, Xuefei, Chen, Qingmei, Ling, Ning, Zhang, Bingqiang, Bi, Yang, Chen, Ke, Ren, Hong, Huang, Ailong, He, Tong-Chuan, Tang, Ni“…BACKGROUND: The Hepatitis C virus (HCV) core protein has been implicated as a potential oncogene or a cofactor in HCV-related hepatocellular carcinoma (HCC), but the underlying mechanisms are unknown. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto